Therapeutic effects of Ginkgo biloba on ischemic manifestations of scleroderma in extremities
Not Applicable
- Conditions
- Scleroderma.Progressive Systemic Sclerosis
- Registration Number
- IRCT201103062053N1
- Lead Sponsor
- Vice Chancellor for Research of Mashhad University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
suffering from scleroderma, suffering from Raynaud's phenomenon, primary level of education, age more than 18 and less than 50 years old, signing the informed consent
Exclusion criteria: consumption of use anticoagulants, consumption of NSAIDs, consumption of mono amino Oxidase inhibitors
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Stiffness of the skin. Timepoint: Every months till 3 month. Method of measurement: Modified Rodnan Skin Score.;Raynaud's Condition. Timepoint: before treatment and at the end of months 1 , 2 , 3. Method of measurement: Raynaud's Condition Score.
- Secondary Outcome Measures
Name Time Method Interval of Raynaud's attack. Timepoint: every month till 3 month. Method of measurement: Patient examination and his/her statement about the condition of his/ her sickness.